Member Info for WeTookPelham

...From 8am yesterday....cheeky.

No RNS about the AGM today as most expected? Interesting no?
Or maybe we'll get a heads up RNS about the RNS first ;)

...on the end of a Scancell RNS? Or maybe I never noticed...
"This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014"
Probably not significant, just curious.

...for a bit of discussion/fun whilst it's quiet, who thinks there maybe more than one RNS tomorrow?
I'm still (yes...still, move on already etc etc) intrigued about last weeks RNS about the RNS, more for the uncharacteristic nature of it more than anything else

"Galectin Therapeutics buries bad news in the hype of a combination cancer drug trial"
https://www.statnews.com/2018/09/21/galectin-therapeutics-buries-bad-news/

"Galectin Therapeutics (GALT) says new clinical trial data disclosed Thursday suggest its experimental cancer drug improves the efficacy of Merck’s blockbuster immunotherapy therapy Keytruda when the two drugs are used together to treat patients with advanced melanoma. No, the new Galectin data — what little there are — show no such thing. "

Unfortunately can't read the rest of the report...

Whereas, it's reported like this elsewhere:
https://finance.yahoo.com/news/galectin-therapeutics-inc-announces-positive-120000449.html
"Galectin Therapeutics, Inc. Announces Positive Preliminary Results from Phase 1b Clinical Trial of GR-MD-02 and KEYTRUDA® in Advanced Melanoma and Expansion of the Trial"

https://www.nasdaq.com/article/galectin-therapeutics-stock-surges-on-early-cancer-combination-trial-results-20180920-00491

http://www.rttnews.com/2936746/galectin-therapeutics-stock-surges-on-early-cancer-combination-trial-results.aspx

...Perhaps significant...perhaps not, as we can be sure Scancell are "very" busy behind the scenes, but there hasn't been single tweet for over three weeks, a long time, relatively speaking.

Do you mean possible insider info/leaky leaky? Because it was already common knowledge that the Final Results were due around now anyway right?

...as to peoples thoughts why this weeks RNS about the upcoming RNS may have triggered all the buying this week (today excluded). Or as some have alluded to, maybe it was just a sheer coincidence?

Agree, very odd if you're going by previous announcements? An RNS to announce another incoming RNS...mmm.
Yes they may just be following RNS protocol (all of a sudden?), but why the coincidental influx of numerous buys? Thoughts?
Either way, as roses says, intriguing.

Just to clarify, are Scancell attending and/or providing abstracts?

Ah...I take it dabrafenib and trametinib is for BRAF-positive stage III melanoma, which is not what SCIB1 is designed for?

...be free on the NHS...

"...combination of the drugs dabrafenib and trametinib" - Are these both both by Novartis?

https://www.bbc.co.uk/news/health-45522796

N.b. "58% of this group survived with no relapse compared to 39% of the placebo group." plus side effects...maybe they need something with better survival rate and less side effects? ;)

"The therapy, which has been approved by the health body NICE - the National Institute for Health and Care Excellence - is a combination of the drugs dabrafenib and trametinib which can be taken at home as five tablets a day.

It comes after a clinical trial of more than 800 patients found a lower risk of the cancer recurring in a group taking the therapy.

Three years after surgery, 58% of this group survived with no relapse compared to 39% of the placebo group.

The therapy was also found to increase the overall length of time people live, by reducing how many people develop an incurable form of the disease.

However there were side effects, including fatigue and nausea, that occurred in a third of patients taking the therapy, and 10% of the placebo group."

Looks like the NHS is on the march with regards to Cancer treatments recently though? What's changed?

Other attendees included Adaptimmune and perhaps more notably Merck Ventures http://www.m-ventures.com

?

Yes I think boredom is the key factor here! This wait for significant SP altering news is somewhat mind numbing!
So any interesting glimmers like Friday provide some rare excitement!

MattRempit, yes my comment was somewhat tongue in cheek, but was curious about other people's thoughts about Fridays trades.

Hi C7, relatively speaking (last few weeks at least) Friday was a very unusual day trading/volume wise, no? Although we have been getting the odd big buy here and there leading up to Friday.
Like you say, wonder if someone knows something :)
Wouldn't want to be to be out of this over the weekend etc etc!!! (Sorry...always wanted to say that ;) )

Hi C7 what is the significance of the Toronto conference RE Scancell, it doesn't look like Scancell are attending are they?
However it looks like every single big hitter is there! Abbvie, Astra, Celenge, Bayer, BMS, Merck, Novartis, Pfizer, Takeda etc!!! This conference must be a biggie then?
Maybe Scancell are attending unofficially? ;)

Forgive me, what's the key differences between this latest report and the last one?

Could the non disclosure/holding back(?) of IND progress news be down to wanting to release a bunch of big news in one go? Someone mentioned this before I think? I.E. IND gets signed off, then boom! Significant partnership news?

TF - you would assume something major is going on, wouldn't you?

Also RE the Novartis NHS deal, it was the main headline on the BBC Breakfast news this morning, so immunotherapy front and centre. In theory could SCIB1 move into use as quickly as that? What would the actual steps involved be from where it is now?